Is This Wall Street Bank Insane to Believe Tesla Will Nearly Double From Current Prices? Maybe Not.

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Dan Ives' $600 Tesla target rests on FSD, robotaxi, and Optimus scaling into software margins by 2027, framing the $25B capex as investment, not destruction.

  • TSLA's Q2 EPS missed estimates by 39% while operating margin collapsed to 1% and free cash flow turned negative as capex surged 142%.

  • GM trades up 7% year to date after five straight EPS beats, while Tesla's selloff didn't spread to RIVN, LCID, or other EV peers.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Tesla didn't make the cut. Grab the names FREE today.

Is This Wall Street Bank Insane to Believe Tesla Will Nearly Double From Current Prices? Maybe Not.

© Dmitry Demidovich / Shutterstock.com

Tesla (NASDAQ:TSLA | TSLA Price Prediction) currently trades at $309.22 against a consensus analyst price target of $401.07, but Wedbush’s Dan Ives issued a $600 call that implies roughly 94% upside from here.

The target assumes Tesla successfully executes a hardware-to-software multiplier, selling vehicles at near-cost to lock in an active base for recurring, high-margin AI, mobility, and robotics subscriptions. Under that premise, the math works. The question is whether the last quarter made it more or less believable.

Wall Street is paying attention because the stock has been cut in half from its year-to-date starting point, even as revenue keeps growing at more than 25% annually.

An Earnings Miss That Blew Up the Margin Story

Q2 2026 earnings triggered the drop. Tesla reported revenue of $28.24 billion, up 25.5% year over year and beating consensus by 7.10%, but non-GAAP EPS came in at $0.33 versus a $0.54 estimate, missing by 38.51%. Operating margin collapsed to 1.4%, operating income fell 56.88% year over year, and free cash flow turned to negative $1.09 billion as capex surged 141.8%.

Shares dropped 16.33% in the past week and 18.56% over the past month. The selloff is Tesla-specific rather than sector-wide, driven by fear that $25 billion capital budget is destroying near-term profitability faster than the AI, robotaxi, and Optimus story is being monetized.

Why Analysts Are Looking Past the Quarter

Bulls anchor on the same lines that hurt the P&L. Services revenue grew 50% year over year, active FSD subscriptions hit 1.48 million, up 56%, and FSD attach rate on new North American deliveries topped 55%. Robotaxi is running in seven US metros, with VP of AI Ashok Elluswamy telling investors the fleet has driven “more than 380,000 miles of unsupervised robotaxi” with “zero notable incidents”, growing at “more than 10% a week”.

Wedbush’s $600 case rests on Optimus, Cybercab, and FSD reaching subscription scale in 2027 and 2028. Elon Musk called Optimus “the biggest product ever”, with aspirational output of 1 million units a year from the third-generation robot and 10 million from the fourth. If those recurring streams materialize with software-like margins, near-cost hardware supports the target.

Of 47 analysts, 5 rate the stock Strong Buy, 18 Buy, 18 Hold, 4 Sell, and 2 Strong Sell. That is a bull-neutral tilt more than an enthusiastic majority, with Wedbush at the aggressive end.

How the Rest of the EV Complex Stacks Up

Tesla fell alone. Peers did not sell off in sympathy, sharpening the argument that this is a Tesla-specific reset rather than an EV sector unwind.

Rivian (NASDAQ:RIVN) trades at $16.48, down 16.39% year to date, against an analyst target of $18.77 for roughly 13.9% upside. The Street is 11 Buy or Strong Buy, 10 Hold, 5 Sell or Strong Sell, a cautious posture ahead of the R2 ramp.

Lucid (NASDAQ:LCID) is at $6.50, off 38.51% year to date, versus a target of $8.30, or about 27.7% upside. Analysts sit at 1 Buy, 8 Hold, and 3 Sell or Strong Sell, with recent revisions trending lower on cash burn.

General Motors (NYSE:GM) trades at $87.04, up 7.53% year to date, with a target of $98.31 and roughly 12.9% upside. Ratings run heavily bullish at 20 Buy or Strong Buy, 5 Hold, 2 Sell or Strong Sell after five straight EPS beats.

The largest analyst-implied upside in the group sits with Tesla, whether measured against the $401 consensus or Wedbush’s $600. The market is punishing Tesla’s AI spending in a way it is not punishing legacy or startup peers.

What the Stock Actually Says

Tesla is down 31.24% year to date while the S&P 500 is up 8.38%. Shares trade below the 50-day moving average of $402.56 and the 200-day at $414.71, with a 52-week low of $297.82 just below the current price.

Valuation is where the debate lives. Trailing P/E of 285 and forward P/E of 156 only make sense if Optimus and robotaxi turn on. Real-money prediction markets are skeptical near term: Polymarket assigns just 15% probability to an Optimus commercial release by year-end 2026, and only 3.1% to shares touching $360 this week.

My Take: Wedbush’s Math Works, But the Timeline Is Long

The bull case works if you accept the multiplier premise: FSD subscriptions compounding above 50% annually, robotaxi mileage growing more than 10% per week, and Optimus reaching meaningful volume within two or three years. In that world, the $25 billion capex bill is the price of admission for a software business inside a car company, and Wedbush’s $600 becomes a math problem grounded in unit economics.

The bear case is that this quarter revealed a structural margin problem instead of a growth investment. Operating margin at 1.4%, free cash flow flipping negative, and EPS missing by 38.51% describe a company still burning cash on ambitions, not one already earning software-like economics. Every quarter of delay on Optimus and Cybercab makes the terminal value harder to defend at 156 times forward earnings.

The target is a two-to-three-year call, not a next-quarter call. Buyers here need patience for the AI thesis to earn back the margin it is currently spending.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

IQV Vol: 3,077,061
INCY Vol: 2,820,895
SHW Vol: 1,994,292
CTSH Vol: 5,886,028
WDAY Vol: 3,663,888

Top Losing Stocks

GLW Vol: 32,177,515
DELL Vol: 6,443,974
MU Vol: 37,565,668
CTRA Vol: 73,319,495
WDC Vol: 6,529,342